StockData
Kazia Therapeutics Ltd logo

Kazia Therapeutics Ltd (KZIA) stock

KZIANasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Nov 17, 2026Score 1/30
$5.49+0.18 (+3.39%)

Close on Nov 18, 2026Market cap $8.89MP/E –Yield –

Kazia Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Kazia Therapeutics's price to book ratio was 0.7× on Jan 31, 2024, against 1.6× a year earlier. Over the last 5 years it ranged from 0.6× to 11.8×, with a median of 2.2×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Jan 31, 20240.7×−0.3
2023Dec 29, 20231.0×+0.3
2022Dec 30, 20220.6×−3.0
2021Dec 31, 20213.6×−2.2
2020Dec 31, 20205.8×+3.3
2019Dec 31, 20192.5×+1.6
2018Dec 31, 20180.9×−6.6
2017Dec 29, 20177.5×–

More Kazia Therapeutics figures

See a number that looks wrong?